DRW Securities, LLC
- SEC CIK
- 0001481986
- Latest filing
- Aug 14, 2026
APTO holding history
Aptose Biosciences Inc. in every 13F filed by DRW Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APTO overviewAll 13F holders of APTOFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,761
- Value
- $32.0K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,761 | $32.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 19,761 | $32.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 19,761 | $29.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 19,761 | $23.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 19,761 | $17.1K | <0.1% | +19,761 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −592,829−100.0% | Sold out | Holders |
| Q4 2024 | 592,829 | $133.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 592,829 | $243.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 592,829 | $450.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 592,829 | $984.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 592,829 | $1.51M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 592,829 | $1.66M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 592,829 | $2.75M | 0.2% | 00.0% | UnchangedConverted for a 1-for-15 split | Holders |
| Q1 2023 | 8,892,437 | $5.69M | 0.8% | 00.0% | Unchanged | Holders |
| Q4 2022 | 8,892,437 | $5.16M | 1.0% | – | No prior filing | Holders |
| Q3 2022 | – | – | – | – | Not filed | Holders |
| Q2 2022 | 8,892,437 | $6.60M | 1.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 8,892,437 | $12.1M | 3.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 8,892,437 | $12.0M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2021 | 8,892,437 | $19.4M | 5.7% | +416,261+4.9% | Added | Holders |
| Q2 2021 | 8,476,176 | $28.1M | 3.8% | +500,000+6.3% | Added | Holders |
| Q1 2021 | 7,976,176 | $47.7M | 16.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.